echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Science News > The world's first human permanent neonatal diabetic canine model comes out

    The world's first human permanent neonatal diabetic canine model comes out

    • Last Update: 2021-11-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    Injection of exogenous insulin to treat permanent neonatal diabetic model dogs, homozygous mutants on the left, chimeric mutants on the right


    Injection of exogenous insulin to treat permanent neonatal diabetic model dogs, homozygous mutants on the left, chimeric mutants on the right


    Diabetes is the third most common disease after cardiovascular diseases and tumors


    GCK

    GCK gene mutations account for a large proportion of juvenile diabetes, and most of them are single-nucleotide mutations.


    GCK

    For the first time, researchers tried to use a single-base editor to make point mutations in the canine GCK gene, so that the CAG codon on the GCK gene was converted from C to T, thereby introducing a stop codon, terminating the translation of GCK early , and completely losing the GCK protein.


    GCK GCK CAG GCK GCK

    In this experiment, a total of 56 fertilized eggs were transplanted, 17 puppies were laid, and 4 GCK gene-edited dogs were obtained , of which 3 were homozygous mutations and 1 was chimera


    GCK GCK

    Researchers conducted GO enrichment analysis on RNA sequencing results and found that permanent neonatal diabetes model dogs injected with exogenous insulin can promote metabolism of lipids and fatty acids, and maintain a relatively normal level of physiological indicators in dogs, thereby enabling Its survival time is prolonged, and these characteristics are consistent with the symptoms of permanent neonatal diabetes in humans


    The single-base gene-edited dog will provide an ideal animal model for studying the mechanism of human neonatal diabetes and developing new treatment methods, such as drug therapy, stem cell therapy and gene therapy


    "Obtaining an animal model that can accurately simulate the disease in humans is of great significance to the research on the occurrence mechanism of the disease and the development of new treatment methods


    Related research work has been funded by the National Key R&D Program, the Strategic Pilot Program of the Chinese Academy of Sciences, and the Guangdong Province and Guangzhou Municipal Science and Technology Programs


    Related paper information: https://doi.


    https://doi.
    org/10.
    1038/s41421-021-00304-y
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.